{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:04:03Z","timestamp":1792976643900,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>\n                           <jats:italic>Summary<\/jats:italic>\n                        <\/jats:title>\n                <jats:p>The Saudi Osteoporosis Society (SOS) has updated its guidelines for the diagnosis and management of osteoporosis in Saudi Arabia (SA), with emphasis on postmenopausal women. This document is relevant to all healthcare professionals in SA involved in the care of patients with osteoporosis and osteoporosis-related fractures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The SOS launched the first national osteoporosis guidelines in 2015 and spearheaded the Gulf Cooperation Council Countries (GCC) osteoporosis consensus report in 2020 which was under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO). This paper highlights a major update of the guidelines in the SA setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This guideline is an adaptation of the current guidelines derived from ESCEO, the American Association of Clinical Endocrinologists (AACE), and the GCC osteoporosis consensus report and studies on osteoporosis done in SA. Where accessible, the timeliest systematic review, meta-analysis, and randomized controlled trials were used as evidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The present update includes new recommendations for the assessment of osteoporosis taking into consideration the Saudi model of FRAX for fracture probabilities, appropriate doses for the maintenance of vitamin D status and calcium, the use of representative blood analytes for therapy monitoring, the use of romosozumab and sequential therapy in the pharmacological management strategies, and the establishment of fracture liaison services to prevent secondary fractures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This updated guideline is for all healthcare professionals involved in osteoporosis and post-fracture care and management in SA and harmonized the most up-to-date changes in the field based on evidence-based medicine for use in the local setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11657-023-01242-w","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T10:02:40Z","timestamp":1684749760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Diagnosis and management of osteoporosis in Saudi Arabia: 2023 key updates from the Saudi Osteoporosis Society"],"prefix":"10.1007","volume":"18","author":[{"given":"Yousef","family":"Al-Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Sulimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Sabico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad M.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almohaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa B.","family":"Alaidarous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem M.","family":"Alkhawashki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alshaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Alrayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser M.","family":"Al-Daghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"4","key":"1242_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5144\/0256-4947.2004.242","volume":"24","author":"H Raef","year":"2004","unstructured":"Raef H, Frayha HH, El-Shaker M, Al-Humaidan A, Conca W, Sieck U, Okane J, Osteoporosis Working Group (2004) Recommendations for the diagnosis and management of osteoporosis: a local perspective. Ann Saudi Med 24(4):242\u201352. https:\/\/doi.org\/10.5144\/0256-4947.2004.242","journal-title":"Ann Saudi Med"},{"issue":"2","key":"1242_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0256-4947.77502","volume":"31","author":"H Raef","year":"2011","unstructured":"Raef H, Al-Bugami M, Balharith S, Moawad M, El-Shaker M, Hassan A, Al-Shaikh A et al (2011) Updated recommendations for the diagnosis and management of osteoporosis: a local perspective. Ann Saudi Med 31(2):111\u201328. https:\/\/doi.org\/10.4103\/0256-4947.77502","journal-title":"Ann Saudi Med"},{"issue":"1","key":"1242_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5144\/0256-4947.2015.1","volume":"35","author":"Y Al-Saleh","year":"2015","unstructured":"Al-Saleh Y, Sulimani R, Sabico S, Raef H, Fouda M, Alshahrani F, Al Shaker M, Al Wahabi B et al (2015) 2015 Guidelines for Osteoporosis in Saudi Arabia: recommendations from the Saudi Osteoporosis Society. Ann Saudi Med 35(1):1\u201312. https:\/\/doi.org\/10.5144\/0256-4947.2015.1","journal-title":"Ann Saudi Med"},{"issue":"1","key":"1242_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.31138\/mjr.28.1.27","volume":"28","author":"NA Jassim","year":"2017","unstructured":"Jassim NA, Adib G, Abdul Rahman YA, Gorial FI, Maghraoui A, Al Suhaili AR, Murtaji A et al (2017) Pan Arab Osteoporosis Society Guidelines for Osteoporosis Management. Mediterr J Rheumatol. 28(1):27\u201332. https:\/\/doi.org\/10.31138\/mjr.28.1.27","journal-title":"Mediterr J Rheumatol."},{"issue":"1","key":"1242_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11657-020-00778-5","volume":"15","author":"Y Al-Saleh","year":"2020","unstructured":"Al-Saleh Y, Al-Daghri NM, Sabico S, Alessa T, Al Emadi S, Alawadi F, Al Qasaabi S et al (2020) Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries\u2019 osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Arch Osteoporos. 15(1):109. https:\/\/doi.org\/10.1007\/s11657-020-00778-5","journal-title":"Arch Osteoporos."},{"issue":"6","key":"1242_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"JA Kanis","year":"1994","unstructured":"Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4(6):368\u201381. https:\/\/doi.org\/10.1007\/BF01622200","journal-title":"WHO Study Group. Osteoporos Int"},{"key":"1242_CR7","unstructured":"About IOF. https:\/\/www.osteoporosis.foundation\/about-us#About-IOF\u00a0"},{"issue":"4","key":"1242_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF01623782","volume":"7","author":"JA Kanis","year":"1997","unstructured":"Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int. 7(4):390\u2013406. https:\/\/doi.org\/10.1007\/BF01623782","journal-title":"Osteoporos Int."},{"issue":"6","key":"1242_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 285(6):785\u201395. https:\/\/doi.org\/10.1001\/jama.285.6.785","journal-title":"JAMA"},{"issue":"6","key":"1242_CR10","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.4158\/ep.16.6.1016","volume":"16","author":"NB Watts","year":"2010","unstructured":"Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M et al (2010) American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract. 16(6):1016\u20139. https:\/\/doi.org\/10.4158\/ep.16.6.1016","journal-title":"Endocr Pract."},{"issue":"1","key":"1242_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11657-018-0510-0","volume":"13","author":"JA Kanis","year":"2018","unstructured":"Kanis JA, Johansson H, Harvey NC, McCloskey EV (2018) A brief history of FRAX. Arch Osteoporos 13(1):118. https:\/\/doi.org\/10.1007\/s11657-018-0510-0","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1242_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11657-022-01085-x","volume":"17","author":"YAL Saleh","year":"2022","unstructured":"Saleh YAL, Sulimani RA, Alomary S, Alnajjar YI, Vandenput L, Liu E et al (2022) Incidence of hip fracture in Saudi Arabia and the development of a FRAX model. Arch Osteoporos 17(1):56. https:\/\/doi.org\/10.1007\/s11657-022-01085-x","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1242_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, Mohammadi M (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 16(1):609. https:\/\/doi.org\/10.1186\/s13018-021-02772-0","journal-title":"J Orthop Surg Res."},{"issue":"1","key":"1242_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s13018-021-02821-8","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M, Shohaimi S et al (2021) Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 16(1):669. https:\/\/doi.org\/10.1186\/s13018-021-02821-8","journal-title":"J Orthop Surg Res."},{"issue":"9","key":"1242_CR15","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","volume":"2","author":"GBD 2019 Fracture Collaborators","year":"2021","unstructured":"GBD 2019 Fracture Collaborators (2021) Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev 2(9):e580\u2013e592. https:\/\/doi.org\/10.1016\/S2666-7568(21)00172-0","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"1242_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"F Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G, Norton N, Halbout P, Cooper C, Lorentzon M et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 15(1):59. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","journal-title":"Arch Osteoporos."},{"issue":"7","key":"1242_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/13696998.2020.1737536","volume":"23","author":"R Aziziyeh","year":"2020","unstructured":"Aziziyeh R, Garcia Perlaza J, Saleem N, Sadat-Ali M, Elsalmawy A, McTavish RK, Duperrouzel C et al (2020) The burden of osteoporosis in Saudi Arabia: a scorecard and economic model. J Med Econ. 23(7):767\u2013775. https:\/\/doi.org\/10.1080\/13696998.2020.1737536","journal-title":"J Med Econ."},{"key":"1242_CR18","unstructured":"MOH Publications. National Plan for Osteoporosis Prevention and Management in KSA.https:\/\/www.moh.gov.sa\/en\/Ministry\/MediaCenter\/Publications\/Pages\/Publications-2019-04-23-001.aspx"},{"issue":"Suppl 1","key":"1242_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update. Endocr Pract 26(Suppl 1):1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"issue":"3","key":"1242_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00223-018-00512-x","volume":"104","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) (2019) Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Calcif Tissue Int 104(3):235\u2013238. https:\/\/doi.org\/10.1007\/s00223-018-00512-x","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1242_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11657-022-01083-z","volume":"17","author":"N Abdulla","year":"2022","unstructured":"Abdulla N, Alsaed OS, Lutf A, Alam F, Abdulmomen I, Al Emadi S, Harvey NC et al (2022) Epidemiology of hip fracture in Qatar and development of a country specific FRAX model. Arch Osteoporos. 17(1):49. https:\/\/doi.org\/10.1007\/s11657-022-01083-z","journal-title":"Arch Osteoporos."},{"issue":"1","key":"1242_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11657-021-01024-2","volume":"16","author":"NM Al-Daghri","year":"2021","unstructured":"Al-Daghri NM, Sabico S, Al-Saleh Y, Sulimani R, Aljohani NJ, Sheshah E, Alodhayani A et al (2021) The application of FRAX in Saudi Arabia. Arch Osteoporos. 16(1):166. https:\/\/doi.org\/10.1007\/s11657-021-01024-2","journal-title":"Arch Osteoporos."},{"issue":"1","key":"1242_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","volume":"31","author":"JA Kanis","year":"2020","unstructured":"Kanis JA, Harvey NC, McCloskey E, Bruy\u00e8re O, Veronese N, Lorentzon M, Cooper C et al (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 31(1):1\u201312. https:\/\/doi.org\/10.1007\/s00198-019-05176-3","journal-title":"Osteoporos Int"},{"issue":"10","key":"1242_CR24","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s12325-019-01063-9","volume":"36","author":"M Lorentzon","year":"2019","unstructured":"Lorentzon M, Branco J, Brandi ML, Bruy\u00e8re O, Chapurlat R, Cooper C, Cortet B et al (2019) Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis. Adv Ther. 36(10):2811\u20132824. https:\/\/doi.org\/10.1007\/s12325-019-01063-9","journal-title":"Adv Ther."},{"key":"1242_CR25","doi-asserted-by":"publisher","first-page":"105920","DOI":"10.1016\/j.jsbmb.2021.105920","volume":"212","author":"NM Al-Daghri","year":"2021","unstructured":"Al-Daghri NM, Hussain SD, Ansari MGA, Khattak MNK, Aljohani N, Al-Saleh Y, Al-Harbi MY et al (2021) Decreasing prevalence of vitamin D deficiency in the central region of Saudi Arabia (2008\u20132017). J Steroid Biochem Mol Biol 212:105920. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105920","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1242_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-016-0295-y","volume":"12","author":"NM Al-Daghri","year":"2017","unstructured":"Al-Daghri NM, Al-Saleh Y, Aljohani N, Sulimani R, Al-Othman AM, Alfawaz H, Fouda M et al (2017) Vitamin D status correction in Saudi Arabia: an experts\u2019 consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO). Arch Osteoporos. 12(1):1. https:\/\/doi.org\/10.1007\/s11657-016-0295-y","journal-title":"Arch Osteoporos."},{"issue":"1","key":"1242_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11657-020-0709-8","volume":"15","author":"Y Al Saleh","year":"2020","unstructured":"Al Saleh Y, Beshyah SA, Hussein W, Almadani A, Hassoun A, Al Mamari A, Ba-Essa E et al (2020) Diagnosis and management of vitamin D deficiency in the Gulf Cooperative Council (GCC) countries: an expert consensus summary statement from the GCC vitamin D advisory board. Arch Osteoporos 15(1):35. https:\/\/doi.org\/10.1007\/s11657-020-0709-8","journal-title":"Arch Osteoporos"},{"issue":"4","key":"1242_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/01.NAJ.0000827356.02005.29","volume":"122","author":"K Rosenberg","year":"2022","unstructured":"Rosenberg K (2022) Bisphosphonates likely beneficial for most older women with osteoporosis. Am J Nurs. 122(4):57. https:\/\/doi.org\/10.1097\/01.NAJ.0000827356.02005.29","journal-title":"Am J Nurs."},{"key":"1242_CR29","doi-asserted-by":"publisher","first-page":"688269","DOI":"10.3389\/fendo.2021.688269","volume":"12","author":"Y Gao","year":"2021","unstructured":"Gao Y, Liu X, Gu Y, Song D, Ding M, Liao L, Wang J et al (2021) The effect of bisphosphonates on fracture healing time and changes in bone mass density: a meta-analysis. Front Endocrinol (Lausanne). 12:688269. https:\/\/doi.org\/10.3389\/fendo.2021.688269","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"1242_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jbmr.3384","volume":"33","author":"P Geusens","year":"2018","unstructured":"Geusens P, Marin F, Kendler DL, Russo LA, Zerbini CA, Minisola S, Body JJ et al (2018) Effects of teriparatide compared with risedronate on the risk of fractures in subgroups of postmenopausal women with severe osteoporosis: the VERO trial. J Bone Miner Res. 33(5):783\u2013794. https:\/\/doi.org\/10.1002\/jbmr.3384","journal-title":"J Bone Miner Res."},{"issue":"7","key":"1242_CR31","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00198-019-04947-2","volume":"30","author":"J Reginster","year":"2019","unstructured":"Reginster J, Bianic F, Campbell R, Martin M, Williams SA, Fitzpatrick LA (2019) Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis. Osteoporos Int. 30(7):1465\u20131473. https:\/\/doi.org\/10.1007\/s00198-019-04947-2","journal-title":"Osteoporos Int."},{"issue":"1","key":"1242_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 17(1):58. https:\/\/doi.org\/10.1007\/s11657-022-01061-5","journal-title":"Arch Osteoporos."},{"issue":"5","key":"1242_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/GME.0000000000001763","volume":"28","author":"R Sun","year":"2021","unstructured":"Sun R, Chu Y, Gao Y, Cheng W, Gao S (2021) Efficacy and safety of endocrine therapy for breast-cancer prevention in high-risk premenopausal or postmenopausal women: a Bayesian network meta-analysis of nine randomized controlled trials. Menopause. 28(5):589\u2013600. https:\/\/doi.org\/10.1097\/GME.0000000000001763","journal-title":"Menopause."},{"key":"1242_CR34","doi-asserted-by":"publisher","first-page":"115081","DOI":"10.1016\/j.bone.2019.115081","volume":"130","author":"EL Simpson","year":"2020","unstructured":"Simpson EL, Martyn-St James M, Hamilton J, Wong R, Gittoes N, Selby P, Davis S (2020) Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis. Bone. 130:115081. https:\/\/doi.org\/10.1016\/j.bone.2019.115081","journal-title":"Bone."},{"key":"1242_CR35","doi-asserted-by":"publisher","first-page":"111682","DOI":"10.1016\/j.exger.2021.111682","volume":"159","author":"F Kang","year":"2022","unstructured":"Kang F, Zou Q, Huang J (2022) The effects of raloxifene on endothelial function and inflammation in postmenopausal women: a meta-analysis of randomized controlled trials. Exp Gerontol. 159:111682. https:\/\/doi.org\/10.1016\/j.exger.2021.111682","journal-title":"Exp Gerontol."},{"issue":"12","key":"1242_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ijcp.12022","volume":"66","author":"DA Hanley","year":"2012","unstructured":"Hanley DA, Adachi JD, Bell A, Brown V (2012) Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract. 66(12):1139\u201346. https:\/\/doi.org\/10.1111\/ijcp.12022","journal-title":"Int J Clin Pract."},{"issue":"6","key":"1242_CR37","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/jbmr.3972","volume":"35","author":"P Chotiyarnwong","year":"2020","unstructured":"Chotiyarnwong P, McCloskey E, Eastell R, McClung MR, Gielen E, Gostage J, McDermott M et al (2020) A pooled analysis of fall incidence from placebo-controlled trials of denosumab. J Bone Miner Res. 35(6):1014\u20131021. https:\/\/doi.org\/10.1002\/jbmr.3972","journal-title":"J Bone Miner Res."},{"issue":"16","key":"1242_CR38","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 375(16):1532\u20131543. https:\/\/doi.org\/10.1056\/NEJMoa1607948","journal-title":"N Engl J Med."},{"issue":"4","key":"1242_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40520-022-02100-4","volume":"34","author":"EM Curtis","year":"2022","unstructured":"Curtis EM, Reginster JY, Al-Daghri N, Biver E, Brandi ML, Cavalier E, Hadji P et al (2022) Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging Clin Exp Res. 34(4):695\u2013714. https:\/\/doi.org\/10.1007\/s40520-022-02100-4","journal-title":"Aging Clin Exp Res."},{"issue":"1","key":"1242_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-021-06095-y","volume":"33","author":"S Singh","year":"2022","unstructured":"Singh S, Dutta S, Khasbage S, Kumar T, Sachin J, Sharma J, Varthya SB (2022) A systematic review and meta-analysis of efficacy and safety of romosozumab in postmenopausal osteoporosis. Osteoporos Int. 33(1):1\u201312. https:\/\/doi.org\/10.1007\/s00198-021-06095-y","journal-title":"Osteoporos Int."},{"issue":"8","key":"1242_CR41","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00198-021-05911-9","volume":"32","author":"N Li","year":"2021","unstructured":"Li N, Hiligsmann M, Boonen A, van Oostwaard MM, de Bot RTAL, Wyers CE, Bours SPG et al (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int. 32(8):1517\u20131530. https:\/\/doi.org\/10.1007\/s00198-021-05911-9","journal-title":"Osteoporos Int."},{"issue":"9","key":"1242_CR42","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s40520-019-01377-2","volume":"32","author":"Y Al Saleh","year":"2020","unstructured":"Al Saleh Y, El Seid ME, Ruhaiyem ME, Al Sayed F, Alkhairy A, Al Zaid S, Al Sayed O et al (2020) Characteristics and outcomes of osteoporotic hip fractures: treatment gaps in a tertiary care center in Riyadh. Saudi Arabia. Aging Clin Exp Res. 32(9):1689\u20131695. https:\/\/doi.org\/10.1007\/s40520-019-01377-2","journal-title":"Saudi Arabia. Aging Clin Exp Res."},{"issue":"1","key":"1242_CR43","first-page":"43","volume":"3","author":"M Fouda","year":"2020","unstructured":"Fouda M, Omair MA, Bin Nasser A, Dabbagh R, AlOmran N, AlWalan L, Aljabrain F et al (2020) Fragility hip fracture: incidence and care-gap at a tertiary hospital in Saudi Arabia. Int J Med Sci Curr Res 3(1):43\u201351","journal-title":"Int J Med Sci Curr Res"},{"issue":"10","key":"1242_CR44","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-022-06435-6","volume":"33","author":"L Vandenput","year":"2022","unstructured":"Vandenput L, Johansson H, McCloskey EV, Liu E, \u00c5kesson KE, Anderson FA, Azagra R et al (2022) Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporos Int. 33(10):2103\u20132136. https:\/\/doi.org\/10.1007\/s00198-022-06435-6","journal-title":"Osteoporos Int."}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-023-01242-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T13:30:43Z","timestamp":1704375043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-023-01242-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1007\/s11657-023-01242-w","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"75"}}